Ebola | ||||||
NEWS | ||||||
Ebola Partnering Clinical Application and Key Side-Effects 2018 Global Ebola Partnering 2010 To 2018 provides an in-depth analysis of the London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore appraisal Partnering by value, by volume, by segments, by number of AMCs, appraiser's tenure, etc. The report also ...
| ||||||
DPW Holdings, Inc. (DPW) Analysts See $-0.13 EPS; Inovio Pharmaceuticals (INO) Sellers ... It has completed, current or planned clinical programs of its proprietary SynCon immunotherapies for HPV-caused pre-cancers and cancers, influenza, prostate cancer, breast/lung/pancreatic cancer, hepatitis C virus, hepatitis B virus, HIV, Ebola, Middle East Respiratory Syndrome, and Zika virus.
| ||||||
See more results | Edit this alert |
You have received this email because you have subscribed to Google Alerts. |
Receive this alert as RSS feed |
Send Feedback |
Tidak ada komentar:
Posting Komentar